Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 90.19 USD 0.48% Market Closed
Market Cap: 112.4B USD
Have any thoughts about
Gilead Sciences Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Gilead Sciences Inc

Current Assets 13.1B
Cash & Short-Term Investments 5B
Receivables 4.6B
Other Current Assets 3.4B
Non-Current Assets 41.5B
PP&E 5.4B
Intangibles 28.9B
Other Non-Current Assets 7.2B
Current Liabilities 11.7B
Other Current Liabilities 11.7B
Non-Current Liabilities 24.4B
Other Non-Current Liabilities 24.4B

Balance Sheet
Gilead Sciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10 027
12 851
8 229
7 588
17 940
11 631
5 997
5 338
5 412
8 428
Cash Equivalents
10 027
12 851
8 229
7 588
17 940
11 631
5 997
5 338
5 412
8 428
Short-Term Investments
101
1 757
3 666
17 922
12 149
12 721
1 411
1 182
973
1 179
Total Receivables
4 635
5 854
4 514
3 851
3 327
3 582
4 892
4 493
4 777
4 660
Accounts Receivables
4 635
5 854
4 514
3 851
3 327
3 582
4 892
4 493
4 777
4 660
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1 386
1 955
1 587
801
814
922
1 683
1 618
1 507
1 787
Other Current Assets
1 565
2 345
1 592
1 661
1 606
1 440
2 013
2 141
1 774
2 374
Total Current Assets
17 714
24 762
19 588
31 823
35 836
30 296
15 996
14 772
14 443
16 085
PP&E Net
1 674
2 276
2 865
3 295
4 006
5 170
5 613
5 663
5 475
5 317
PP&E Gross
1 674
2 276
0
3 295
4 006
5 170
5 613
5 663
5 475
5 317
Accumulated Depreciation
620
763
0
994
1 191
1 422
1 668
1 893
2 186
2 449
Intangible Assets
11 073
10 247
8 971
17 100
15 738
13 786
33 126
33 455
28 894
26 454
Goodwill
1 172
1 172
1 172
4 159
4 117
4 117
8 108
8 332
8 314
8 314
Long-Term Investments
1 598
11 601
20 495
11 194
1 423
1 488
502
1 309
1 245
1 163
Other Long-Term Assets
1 433
1 658
3 886
2 712
2 555
6 770
5 062
4 421
4 800
4 792
Other Assets
1 172
1 172
1 172
4 159
4 117
4 117
8 108
8 332
8 314
8 314
Total Assets
34 664
N/A
51 716
+49%
56 977
+10%
70 283
+23%
63 675
-9%
61 627
-3%
68 407
+11%
67 952
-1%
63 171
-7%
62 125
-2%
Liabilities
Accounts Payable
955
1 178
1 206
814
790
713
844
705
905
550
Accrued Liabilities
4 084
7 257
7 775
7 271
6 876
6 254
7 198
7 600
7 100
7 724
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
483
982
0
2 747
2 748
2 499
2 757
1 516
2 273
1 798
Other Current Liabilities
239
473
237
803
191
293
598
1 789
959
1 208
Total Current Liabilities
5 761
9 890
9 218
11 635
10 605
9 759
11 397
11 610
11 237
11 280
Long-Term Debt
11 936
21 075
26 346
30 795
24 574
22 094
28 645
25 179
22 957
23 189
Deferred Income Tax
51
0
0
0
0
0
0
4 356
2 673
1 588
Minority Interest
393
579
476
59
147
125
19
5
31
84
Other Liabilities
1 097
1 638
2 050
7 352
6 962
7 124
10 144
5 743
5 095
3 319
Total Liabilities
19 238
N/A
33 182
+72%
38 090
+15%
49 841
+31%
42 288
-15%
39 102
-8%
50 205
+28%
46 883
-7%
41 931
-11%
39 292
-6%
Equity
Common Stock
2
1
1
1
1
1
1
1
1
1
Retained Earnings
12 732
18 001
18 154
19 012
19 024
19 388
14 381
16 324
15 687
16 304
Additional Paid In Capital
2 391
444
454
1 264
2 282
3 051
3 880
4 661
5 550
6 500
Unrealized Security Profit/Loss
12
16
16
194
52
1
2
4
33
5
Other Equity
289
104
294
29
132
84
62
87
35
33
Total Equity
15 426
N/A
18 534
+20%
18 887
+2%
20 442
+8%
21 387
+5%
22 525
+5%
18 202
-19%
21 069
+16%
21 240
+1%
22 833
+8%
Total Liabilities & Equity
34 664
N/A
51 716
+49%
56 977
+10%
70 283
+23%
63 675
-9%
61 627
-3%
68 407
+11%
67 952
-1%
63 171
-7%
62 125
-2%
Shares Outstanding
Common Shares Outstanding
1 499
1 422
1 307
1 308
1 282
1 266
1 254
1 254
1 247
1 246

See Also

Discover More